All In Biotech

Drug Trial Radar · NCT00107887

TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)

Impact of TB Preventive Therapy for HIV/TB Co-infected Patients With Access to Highly Active Antiretroviral Therapy in Rio de Janeiro, Brazil: A Phased Implementation Trial

Last checked: Nov 19, 2026Latest source record: Jun 15, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 17,415 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

17,415

Actual

Start

Jun 2005

Primary completion

Dec 2010

Study completion Dec 2010

Sponsor

Lead sponsor
Johns Hopkins UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Consortium to Respond Effectively to the AIDS/Tuberculosis Epidemic; Communicable Disease Program, Brazil; Bill and Melinda Gates Foundation
First posted
Apr 12, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if implementing a policy of widespread INH (Isoniazid) prophylaxis therapy in HIV-infected patients with access to antiretroviral therapy reduces the incidence of active TB disease in the HIV clinic population.

Conditions

  • Tuberculosis
  • HIV Infections

Interventions

  • INH preventive therapyDrug

    Clinics will receive training regarding the use of IPT for prevention of Tuberculosis

  • TST (tuberculin skin test)Drug

    Clinics will be trained in the use of TST for assessing exposure to TB

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Measured incidence of active TB in HIV clinic population before and following implementation of IPT policyTime frame: 6 Years
  2. Comparative impact of IPT (Isoniazid Preventive Therapy) and ARVs (antiretrovirals) on TB incidence in the HIV clinic populationTime frame: 6 Years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • City of Rio De Janeiro Health Department Clinics

    Rio de Janeiro, Rio de Janeiro, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.